Literature DB >> 22057664

Distinct regulation of stearoyl-CoA desaturase 1 gene expression by cis and trans C18:1 fatty acids in human aortic smooth muscle cells.

M Minville-Walz1, J Gresti, L Pichon, S Bellenger, J Bellenger, M Narce, M Rialland.   

Abstract

Consumption of trans fatty acids is positively correlated with cardiovascular diseases and with atherogenic risk factors. Trans fatty acids might play their atherogenic effects through lipid metabolism alteration of vascular cells. Accumulation of lipids in vascular smooth muscle cells is a feature of atherosclerosis and a consequence of lipid metabolism alteration. Stearoyl-CoA desaturase 1 (scd1) catalyses the production of monounsaturated fatty acids (e.g. oleic acid) and its expression is associated with lipogenesis induction and with atherosclerosis development. We were interested in analysing the regulation of delta-9 desaturation rate and scd1 expression in human aortic smooth muscle cells (HASMC) exposed to cis and trans C18:1 fatty acid isomers (cis-9 oleic acid, trans-11 vaccenic acid or trans-9 elaidic acid) for 48 h at 100 μM. Treatment of HASMC with these C18:1 fatty acid isomers led to differential effects on delta-9 desaturation; oleic acid repressed the desaturation rate more potently than trans-11 vaccenic acid, whereas trans-9 elaidic acid increased the delta-9 desaturation rate. We then correlated the delta-9 desaturation rate with the expression of scd1 protein and mRNA. We showed that C18:1 fatty acids controlled the expression of scd1 at the transcriptional level in HASMC, leading to an increase in scd1 mRNA content by trans-9 elaidic acid treatment, whereas a decrease in scd1 mRNA content was observed with cis-9 oleic acid and trans-11 vaccenic acid treatments. Altogether, this work highlights a differential capability of C18:1 fatty acid isomers to control scd1 gene expression, which presumes of different consequent effects on cell functions.

Entities:  

Year:  2011        PMID: 22057664      PMCID: PMC3316751          DOI: 10.1007/s12263-011-0258-2

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  45 in total

Review 1.  Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

Authors:  Victor J Dzau; Ruediger C Braun-Dullaeus; Daniel G Sedding
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes.

Authors:  A M Sessler; N Kaur; J P Palta; J M Ntambi
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

3.  Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates.

Authors:  Jian Wang; Lan Yu; Robert E Schmidt; Chen Su; Xiaodi Huang; Kenneth Gould; Guoqing Cao
Journal:  Biochem Biophys Res Commun       Date:  2005-07-08       Impact factor: 3.575

4.  Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2.

Authors:  D E Tabor; J B Kim; B M Spiegelman; P A Edwards
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

5.  Vaccenic acid (t11-18:1) is converted to c9,t11-CLA in MCF-7 and SW480 cancer cells.

Authors:  Aine Miller; Emma McGrath; Catherine Stanton; Rosaleen Devery
Journal:  Lipids       Date:  2003-06       Impact factor: 1.880

6.  Lipid accumulation in arterial smooth muscle cells in culture. Morphological and biochemical changes caused by low density lipoproteins and chloroquine.

Authors:  D S Leake; T J Peters
Journal:  Atherosclerosis       Date:  1982-09       Impact factor: 5.162

7.  Fatty acids induce apoptosis in human smooth muscle cells depending on chain length, saturation, and duration of exposure.

Authors:  Michaela Artwohl; Andrea Lindenmair; Michael Roden; Werner-Klaus Waldhäusl; Angelika Freudenthaler; Gabriele Klosner; Aysegül Ilhan; Anton Luger; Sabina M Baumgartner-Parzer
Journal:  Atherosclerosis       Date:  2008-05-28       Impact factor: 5.162

8.  The anticarcinogenic effect of trans-11 18:1 is dependent on its conversion to cis-9, trans-11 CLA by delta9-desaturase in rats.

Authors:  Adam L Lock; Benjamin A Corl; David M Barbano; Dale E Bauman; Clement Ip
Journal:  J Nutr       Date:  2004-10       Impact factor: 4.798

9.  Dietary trans fatty acids and composition of human atheromatous plaques.

Authors:  Ewa Stachowska; Barbara Dołegowska; Dariusz Chlubek; Teresa Wesołowska; Kazimierz Ciechanowski; Piotr Gutowski; Halina Szumiłowicz; Radosław Turowski
Journal:  Eur J Nutr       Date:  2004-01-27       Impact factor: 5.614

10.  Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.

Authors:  Guosheng Liang; Jian Yang; Jay D Horton; Robert E Hammer; Joseph L Goldstein; Michael S Brown
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

View more
  12 in total

1.  Individual trans 18:1 isomers are metabolised differently and have distinct effects on lipogenesis in 3T3-L1 adipocytes.

Authors:  P Vahmani; W J Meadus; T D Turner; P Duff; D C Rolland; C Mapiye; M E R Dugan
Journal:  Lipids       Date:  2014-12-28       Impact factor: 1.880

2.  Trans Fatty Acids Suppress TNF-α-Induced Inflammatory Gene Expression in Endothelial (HUVEC) and Hepatocellular Carcinoma (HepG2) Cells.

Authors:  Marine S Da Silva; Pierre Julien; Jean-François Bilodeau; Olivier Barbier; Iwona Rudkowska
Journal:  Lipids       Date:  2017-03-18       Impact factor: 1.880

3.  Saturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity.

Authors:  Masashi Masuda; Shinobu Miyazaki-Anzai; Audrey L Keenan; Kayo Okamura; Jessica Kendrick; Michel Chonchol; Stefan Offermanns; James M Ntambi; Makoto Kuro-O; Makoto Miyazaki
Journal:  J Clin Invest       Date:  2015-10-26       Impact factor: 14.808

4.  Double Bond Position Plays an Important Role in Delta-9 Desaturation and Lipogenic Properties of Trans 18:1 Isomers in Mouse Adipocytes.

Authors:  P Vahmani; W J Meadus; C Mapiye; P Duff; D C Rolland; M E R Dugan
Journal:  Lipids       Date:  2015-10-17       Impact factor: 1.880

5.  Elaidic acid increases hepatic lipogenesis by mediating sterol regulatory element binding protein-1c activity in HuH-7 cells.

Authors:  Fei Shao; David A Ford
Journal:  Lipids       Date:  2014-01-31       Impact factor: 1.880

6.  Fatty acid composition of adipose tissue triglycerides after weight loss and weight maintenance: the DIOGENES study.

Authors:  M Kunešová; P Hlavatý; E Tvrzická; B Staňková; P Kalousková; N Viguerie; T M Larsen; M A van Baak; S A Jebb; J A Martinez; A F H Pfeiffer; A Kafatos; T Handjieva-Darlenska; M Hill; D Langin; A Zák; A Astrup; W H M Saris
Journal:  Physiol Res       Date:  2012-10-25       Impact factor: 1.881

7.  Oleic acid modulates mRNA expression of liver X receptor (LXR) and its target genes ABCA1 and SREBP1c in human neutrophils.

Authors:  María Edith Reyes-Quiroz; Gonzalo Alba; Javier Saenz; Consuelo Santa-María; Isabel Geniz; Juan Jiménez; Remedios Ramírez; José Martín-Nieto; Elizabeth Pintado; Francisco Sobrino
Journal:  Eur J Nutr       Date:  2014-04-11       Impact factor: 5.614

8.  A trans10-18:1 enriched fraction from beef fed a barley grain-based diet induces lipogenic gene expression and reduces viability of HepG2 cells.

Authors:  Payam Vahmani; William J Meadus; Maria L P da Silva; Alec D Mitchell; Cletos Mapiye; Pascale Duff; David C Rolland; Michael E R Dugan
Journal:  Biochem Biophys Rep       Date:  2016-05-27

9.  Host lipid droplets: An important source of lipids salvaged by the intracellular parasite Toxoplasma gondii.

Authors:  Sabrina J Nolan; Julia D Romano; Isabelle Coppens
Journal:  PLoS Pathog       Date:  2017-06-01       Impact factor: 6.823

10.  Relationship between central and peripheral fatty acids in humans.

Authors:  Jade Guest; Manohar Garg; Ayse Bilgin; Ross Grant
Journal:  Lipids Health Dis       Date:  2013-05-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.